Enalapril for painful venous malformations
Treatments studied
Part of Genetic & congenital, Heart & circulation, Pain clinical trials.
This trial tests if the blood pressure drug enalapril can reduce pain from venous malformations (abnormal veins). It may help people whose pain limits daily activities or interrupts sleep.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a venous malformation that causes pain bad enough to affect your daily life or sleep.
- You are between 18 and 70 years old.
- Your malformation has clear borders and can be measured on an MRI.
- You do not have diabetes, serious heart, kidney, or liver problems.
- You are not pregnant and use effective birth control if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the drug everolimus for people with certain types of vascular anomalies (tumors or malformations in blood vessels) that have not improved with other treatments. It aims to see if everolimus can help shrink these growths or control their symptoms.
This trial tests whether a direct oral anticoagulant (a blood thinner) can reduce pain from venous malformations that also cause a blood clotting problem (localized intravascular coagulation, or LIC). It may help people whose pain interferes with daily activities or sleep.
This trial tests a new implantable valve designed to treat severe leg swelling and skin damage caused by faulty deep veins that have stopped working properly. The valve may help prevent complications and improve symptoms after standard treatments haven't fully worked.
This trial tests if blocking enlarged veins in the pelvis (called embolization) can reduce long-term pelvic pain that hasn't improved with other treatments. It may help women whose pain is worse when standing or walking and better when lying down.
This study tests a drug called everolimus to see if it helps treat vascular malformations (abnormal clusters of blood vessels). It is for adults aged 18 to 65 who have been diagnosed by MRI and are able to take oral medication.
This trial tests whether the study drug KP-001 can help reduce symptoms like pain, fatigue, or bleeding caused by certain vascular malformations (abnormal blood vessel growths) that can't be surgically removed or haven't responded to other treatments. It's for people age 2 and older with specific conditions such as common venous malformations, lymphatic malformations, or KTS/CLOVES syndrome.
Hear when a new Venous Malformation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.